Healthcare and Life Science
Exploring treatment options for ILD
Interstitial lung disease (ILD) refers to a group of lung disorders that cause inflammation and scarring of lung tissue, leading to progressive breathing difficulties. While there is currently no cure for ILD, treatment focuses on controlling symptoms, slowing disease progression, and i...
ELRIG announces keynote speakers for Drug Discovery 2025
Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”Event supported by VisitBritain showcases UK life science sector and extends international reachCambridge, UK, 07 May 2...
PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics
Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive DirectorStrategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platformCambridge, UK, 7 May 2025: PhoreMost...
Trilobio raises $8M to deliver whole lab automation for biologists
San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, announces it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized Capital, including participation from Argon Ventures and L...
PlaqueTec announces positive early research findings from interim analysis in BIOPATTERN trial
Pre-specified interim analysis reveals differences in protein concentration between systemic blood and blood from diseased coronary arteries Safety and functionality data for the updated Liquid Biopsy System supports continuation of the BIOPATTERN trial ...
Nuclera establishes distribution network across APAC and the Middle East
Operational expansion accelerates global distribution capability to increase regional access and technical supportMultiple partnerships establish direct distribution channels in China, Japan, South Korea, Singapore and IsraelCambridge, UK, and Boston MA, USA, 06 May 2025: Nuclera, the b...
Deloitte 2025 Technology Fast 50: The fastest growing tech companies in the UK Applications now open!
We’re delighted to announce that nominations for the 2025 UK Technology Fast 50 awards are now open! Apply today and you could join the likes of Deliveroo, Revolut and Skyscanner as a UK Technology Fast 50 winner. Application deadline: Midnight, Friday 27 June 2025 ...
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector
Established biotech leader with over 20 years’ experience including at OXB and LifeArc driving commercialization to support CGT downstream manufacturingMichele Pedrocchi PhD appointed as Non-Executive Chair of the Board of DirectorsBedfordshire, UK, 1 May 2025: Tozaro, an emerging techn...
Sapio Sciences introduces Biorepository Management Solution in Sapio Release 25.4
Latest release of Sapio Platform streamlines sample workflows and delivers centralized, compliant biospecimen management ...
RxCelerate assembles a world-class scientific advisory board for its Biologics Discovery Unit
RxCelerate, the award-winning drug discovery and development platform, has unveiled a world-class Scientific Advisory Board (SAB) for its rapidly growing antibody discovery group, RxBiologics. ...